Top compounds associated with response to MARK2


Feature Type Standardized
Nominal ANOVA
mRNA myricetin CTRPv2 pan-cancer AAC -0.018 0.7
mRNA GDC-0941 gCSI pan-cancer AAC 0.03 0.7
mRNA Axitinib FIMM pan-cancer AAC 0.076 0.7
mRNA Bortezomib FIMM pan-cancer AAC -0.069 0.7
mRNA Sorafenib FIMM pan-cancer AAC 0.079 0.7
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA BIBR-1532 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.016 0.7
mRNA istradefylline CTRPv2 pan-cancer AAC 0.026 0.7
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.015 0.7
Download CSV